Prolonged Clinical Benefit with Futibatinib in a Patient with FGFR Inhibitor–Pretreated FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma: Case Report

d'Arienzo PD, MacDonald AR, Patel V, Ma YT, Pihlak R, Starling N

OncoTargets and Therapy 2024, 17:489-496

Published Date: 13 June 2024